Legal Opinion
In Re Ciprofloxacin Hydrochloride Antitrust Litigation
District Court, E.D. New York
Decided March 31, 2005No. 1:00MDL1383DGTPublishedCited by 26 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
TRAGER, District Judge.
This action involves agreements between the brand-name manufacturer of the widely used antibiotic ciprofloxacin hydrochloride (“Cipro”) and potential generic manufacturers of Cipro. The brand-name manufacturer, Bayer AG, a German company, and its American subsidiary, Bayer Corporation (collectively, “Bayer”) and the generics, Barr Laboratories, Inc. (“Barr”); The Rugby Group, Inc. (“Rugby”); Hoechst Marion Roussel, Inc. (“HMR”); and Watson Pharmaceuticals, Inc. (“Watson”) (collectively, “generic defendants”) 1 entered into agreements that Direct…
2Cases cited54 opinions
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Christianson v. Colt Industries Operating Corp.Supreme Court of the United States · 1988
- Zenith Radio Corp. v. Hazeltine Research, Inc.Supreme Court of the United States · 1969
- Brown Shoe Co. v. United StatesSupreme Court of the United States · 1962
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
49 more not listed; retrieve them via the Exa API.
3Cited by26 opinions
- In Re DDAVP Direct Purchaser Antitrust LitigationCourt of Appeals for the Second Circuit · 2009
- Joblove v. Barr Labs. Inc.Court of Appeals for the Second Circuit · 2005
- In Re Lipitor Antitrust LitigationCourt of Appeals for the Third Circuit · 2017
- Meijer, Inc. v. Ferring B.V.District Court, S.D. New York · 2012
- In re Cipro Cases I & IICalifornia Supreme Court · 2015
21 more not listed; retrieve them via the Exa API.